Skip to main content

previous disabled Page of 4
and
  1. Article

    Open Access

    European LeukemiaNet-defined primary refractory acute myeloid leukemia: the value of allogeneic hematopoietic stem cell transplant and overall response

    We sought to appraise the value of overall response and salvage chemotherapy, inclusive of allogeneic hematopoietic stem cell transplant (AHSCT), in primary refractory acute myeloid leukemia (prAML). For estab...

    K. H. Begna, J. Kittur, N. Gangat, H. Alkhateeb, M. S. Patnaik in Blood Cancer Journal (2022)

  2. Article

    Open Access

    Extramedullary hematopoiesis in the absence of myeloproliferative neoplasm: Mayo Clinic case series of 309 patients

    N. Fan, S. Lavu, C. A. Hanson, A. Tefferi in Blood Cancer Journal (2018)

  3. No Access

    Article

    Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

    A Tefferi, T L Lasho, C Finke, N Gangat, C A Hanson, R P Ketterling in Leukemia (2018)

  4. Article

    Open Access

    Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients

    In a recent International Working Group on Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) study, prior arterial events and hypertension were predictors of subsequent arterial thrombosis whereas ...

    S. Cerquozzi, D. Barraco, T. Lasho, C. Finke, C. A. Hanson in Blood Cancer Journal (2017)

  5. Article

    Open Access

    Application of current prognostic models for primary myelofibrosis in the setting of post-polycythemia vera or post-essential thrombocythemia myelofibrosis

    A Tefferi, L Saeed, C A Hanson, R P Ketterling, A Pardanani, N Gangat in Leukemia (2017)

  6. Article

    Open Access

    Liver function test abnormalities and their clinical relevance in primary myelofibrosis

    D Barraco, M Mudireddy, S Shah, C A Hanson, R P Ketterling in Blood Cancer Journal (2017)

  7. Article

    Open Access

    Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations

    In 2012, the International Working Group for Myeloproliferative Neoplasms (MPN) Research and Treatment (IWG-MRT) reported an associations between mild bone marrow (BM) fibrosis (⩾grade 1) in polycythemia vera ...

    D Barraco, S Cerquozzi, C A Hanson, R P Ketterling, A Pardanani in Blood Cancer Journal (2017)

  8. Article

    Open Access

    Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

    Current prognostic models for myelodysplastic syndromes (MDS), including the Revised International Prognostic Scoring System (IPSS-R), do not account for host immunity. We retrospectively examined the prognost...

    L Saeed, M M Patnaik, K H Begna, A Al-Kali, M R Litzow, C A Hanson in Blood Cancer Journal (2017)

  9. No Access

    Article

    Vascular events and risk factors for thrombosis in refractory anemia with ring sideroblasts and thrombocytosis

    M M Patnaik, T L Lasho, C M Finke, C A Hanson, R L King, R P Ketterling in Leukemia (2016)

  10. Article

    Open Access

    MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia

    M Haider, Y C Elala, N Gangat, C A Hanson, A Tefferi in Blood Cancer Journal (2016)

  11. Article

    Open Access

    Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance

    M M Patnaik, M F Zahid, T L Lasho, C Finke, R L Ketterling in Blood Cancer Journal (2016)

  12. No Access

    Article

    Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing

    A Pardanani, T Lasho, E Wassie, C Finke, D Zblewski, C A Hanson, R P Ketterling in Leukemia (2016)

  13. Article

    Erratum: Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

    Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

    D Barraco, Y C Elala, T L Lasho, K H Begna, N Gangat, C Finke in Blood Cancer Journal (2016)

  14. Article

    Open Access

    Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

    N Gangat, M M Patnaik, K Begna, A Al-Kali, M R Litzow in Blood Cancer Journal (2016)

  15. Article

    Open Access

    Molecular correlates of anemia in primary myelofibrosis: a significant and independent association with U2AF1 mutations

    D Barraco, Y C Elala, T L Lasho, K H Begna, N Gangat, C Finke in Blood Cancer Journal (2016)

  16. No Access

    Article

    CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value

    CD123 is the α-subunit of the interleukin-3 receptor; it represents a potential therapeutic target in systemic mastocytosis (SM) given its absent expression on normal/reactive mast cells (MCs) and aberrant exp...

    A Pardanani, K K Reichard, D Zblewski, R A Abdelrahman, E A Wassie in Leukemia (2016)

  17. Article

    Open Access

    Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

    A Tefferi, A Al-Kali, K H Begna, M M Patnaik, T L Lasho, A Rizo in Blood Cancer Journal (2016)

  18. Article

    Open Access

    Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

    Mutations involving epigenetic regulators (TET2~60% and ASXL1~40%) and splicing components (SRSF2~50%) are frequent in chronic myelomonocytic leukemia (CMML). On a 27-gene targeted capture panel performed on 175 ...

    M M Patnaik, T L Lasho, P Vijayvargiya, C M Finke, C A Hanson in Blood Cancer Journal (2016)

  19. No Access

    Article

    Aberrant expression of CD123 (interleukin-3 receptor-α) on neoplastic mast cells

    A Pardanani, T Lasho, D Chen, T K Kimlinger, C Finke, D Zblewski, M M Patnaik in Leukemia (2015)

  20. Article

    Open Access

    Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

    A Pardanani, R A Abdelrahman, C Finke, T T Lasho, K H Begna, A Al-Kali in Leukemia (2015)

previous disabled Page of 4